What are the different types of laxatives, their indications, recommended doses, precautions, and side effects?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Types of Laxatives: Indications, Doses, Precautions, and Side Effects

Osmotic laxatives (particularly PEG) and stimulant laxatives are the preferred first-line agents for constipation, with osmotic agents generally better tolerated for longer-term use. 1

Laxative Categories and Clinical Use

1. Osmotic Laxatives (Preferred for Most Situations)

These agents draw water into the intestine to hydrate and soften stool 1.

Polyethylene Glycol (PEG/Macrogol) - FIRST CHOICE

  • Indications: Chronic constipation, opioid-induced constipation, IBS-C 2
  • Mechanism: Virtually no net gain or loss of sodium and potassium; well-tolerated osmotic effect 2
  • Dosing: Typically 17g powder dissolved in water once daily; titrate to effect
  • Advantages: Most effective osmotic agent; maintains efficacy long-term; minimal electrolyte disturbances 2, 3
  • Side Effects: Abdominal pain, bloating (generally mild) 4
  • Precautions: Requires adequate fluid intake 2

Lactulose

  • Indications: Chronic constipation, hepatic encephalopathy
  • Mechanism: Not absorbed by small bowel; bacterial fermentation in colon 2
  • Dosing: 15-30 mL once or twice daily
  • Onset: 2-3 days latency before effect 2
  • Side Effects: Sweet taste intolerance, nausea, abdominal distention, flatulence, bloating, cramping (common and often poorly tolerated) 2, 3
  • Note: Less preferred than PEG due to side effect profile 1

Magnesium Salts (Magnesium Hydroxide/Citrate)

  • Indications: Acute constipation, bowel preparation
  • Dosing: Magnesium hydroxide 30-60 mL daily; magnesium citrate 150-300 mL as single dose
  • Side Effects: Diarrhea, abdominal cramping
  • Precautions: Use cautiously in renal impairment - excessive doses can cause hypermagnesemia 2. Contraindicated in severe renal dysfunction 5

2. Stimulant Laxatives (Short-term or Rescue Therapy)

These agents irritate sensory nerve endings to stimulate colonic motility and reduce water absorption 1.

Bisacodyl and Sodium Picosulfate

  • Indications: Refractory constipation, short-term use, rescue therapy 2, 6
  • Mechanism: Converted to active metabolite (BHPM) that stimulates colonic peristalsis 6
  • Dosing:
    • Start with 5 mg orally (not the 10 mg used in trials - side effects are common at higher doses) 6
    • Bisacodyl suppository: 10 mg rectally (works in 30-60 minutes)
    • Oral onset: 6-12 hours; best taken at bedtime 2, 6
  • Side Effects: Diarrhea (31-53%), abdominal pain/cramping (5-25%) - most occur in first week 6
  • Precautions: Contraindicated in ileus, intestinal obstruction, severe dehydration, acute inflammatory bowel conditions 6
  • Important Note: Despite widespread concern, there is little evidence that routine use is harmful to the colon 1
  • Clinical Use: Recommended for short-term or rescue therapy due to side effect profile; long-term effectiveness not well studied 6

Senna (Anthranoid Compounds)

  • Indications: Constipation, particularly when taken at bedtime
  • Mechanism: Hydrolyzed by colonic bacteria to active molecules; motor and secretory effects 2
  • Dosing: Start 8.6-17.2 mg at bedtime; trials used up to 1g daily (higher than typical practice) 6
  • Timing: Take in evening/bedtime for morning bowel movement 2
  • Side Effects: Abdominal cramping, diarrhea (dose-dependent) 6
  • Precautions: Wide variation in clinical effectiveness; stimulating effect may be too great for weak or debilitated patients 2
  • Note: Antibiotic use can decrease efficacy (affects bacterial conversion) 6

3. Stool Softeners/Detergents (Generally NOT Recommended)

Docusate Sodium

  • Mechanism: Surfactant allowing water and lipids to penetrate stool 1
  • Evidence: Based on inadequate experimental evidence in palliative care 2
  • Clinical Reality: Widely used but effectiveness questionable; not recommended as primary agent 2

4. Lubricants (Generally NOT Recommended)

Mineral Oil (Liquid Paraffin)

  • Mechanism: Softens and lubricates stool 1
  • Precautions:
    • Risk of lipoid pneumonia if aspirated 2
    • Anal seepage, skin excoriation
    • Foreign body reaction if anorectal mucosa break
  • Evidence: Less effective than PEG 2
  • Status: Largely obsolete from general medical perspective; limited role in palliative care 3

5. Bulk-Forming Laxatives (NOT Recommended in Advanced Disease)

Psyllium, Methylcellulose

  • Indications: Patients who cannot take adequate dietary fiber
  • Mechanism: Increase stool bulk and water content
  • Precautions:
    • Requires adequate fluid intake 2
    • Effectiveness wanes over time
    • Not recommended for opioid-induced constipation 2
    • Not suitable for palliative care patients unable to maintain fluid intake 3
  • Side Effects: Bloating, allergic reactions (particularly psyllium) 5

6. Rectal Agents (Suppositories and Enemas)

Indications

Preferred first-line therapy when digital rectal exam identifies full rectum or fecal impaction 2

Suppositories

  • Types: Glycerine, bisacodyl, CO2-releasing compounds 2
  • Mechanism: Soften stool and stimulate rectal motility
  • Advantages: Work more quickly than oral laxatives; effective for short-term treatment 2

Enemas

  • Indications: When oral treatment fails after several days; prevention of fecal impaction 2
  • Types: Hyperosmotic saline, small-volume self-administered
  • Administration: Large-volume enemas should be administered by experienced health professional 2
  • Precautions:
    • Risk of intestinal perforation (suspect if abdominal pain occurs)
    • Rectal mucosal damage
    • Bacteremia
    • Use cautiously in patients on anticoagulation 2

Clinical Algorithm for Laxative Selection

Step 1: Assess Clinical Situation

  • Full rectum/fecal impaction on exam → Suppository or enema first 2
  • Opioid-induced constipation → PEG or stimulant laxatives as first-line 1
  • Chronic idiopathic constipation → PEG as first-line 2, 6
  • IBS-C → PEG (conditional recommendation) 7
  • Advanced cancer/palliative care → PEG preferred if adequate fluid intake possible 2, 3

Step 2: First-Line Oral Therapy

Start with PEG - best evidence for efficacy and tolerability 2, 1, 2

  • Dose: 17g daily, titrate as needed
  • If inadequate response after adequate trial, add or switch to stimulant laxative

Step 3: Rescue or Refractory Cases

  • Add bisacodyl 5mg at bedtime or senna 8.6-17.2mg at bedtime 6
  • Consider rectal agents if no response within 2-3 days
  • For opioid-induced constipation refractory to laxatives, consider peripherally acting μ-opioid receptor antagonists (PAMORAs) 1

Step 4: Avoid in Most Cases

  • Docusate (inadequate evidence) 2
  • Mineral oil (aspiration risk, less effective) 2
  • Bulk laxatives in advanced disease or when fluid intake limited 2

Key Precautions Across All Laxatives

  1. Renal impairment: Avoid or use cautiously with magnesium-containing products 2
  2. Intestinal obstruction/ileus: Contraindication for stimulant laxatives 6
  3. Adequate hydration: Essential for osmotic laxatives and bulk agents 2
  4. Pregnancy/lactation: Older laxatives (osmotic, stimulant) are safe; newer agents lack data 8
  5. Electrolyte disturbances: Rare with therapeutic doses; occur mainly with excessive use 5, 9

Common Pitfalls to Avoid

  • Starting stimulant laxatives at 10mg: Begin with 5mg to minimize diarrhea and cramping 6
  • Using docusate as primary agent: Inadequate evidence for effectiveness 2
  • Prescribing bulk laxatives without ensuring adequate fluid intake: Risk of obstruction 2
  • Avoiding stimulant laxatives due to "cathartic colon" concerns: This is not supported by modern evidence 1
  • Using lactulose when PEG is available: PEG better tolerated with fewer side effects 2, 1, 3
  • Delaying rectal agents when impaction present: Suppositories/enemas are first-line for impaction 2

References

3
Research

Constipation--modern laxative therapy.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2003

5
Research

Adverse effects of laxatives.

Diseases of the colon and rectum, 2001

9
Research

[Side effects of laxatives].

Zeitschrift fur Gastroenterologie, 1992

Related Questions

How many seconds does 74 large boxes represent on an electrocardiogram (ECG)?
What is the appropriate workup and treatment for a 75-year-old woman with acute swollen fingers limiting movement?
How should a retained left fallopian tube after a hysterectomy performed 30 years ago be evaluated and managed?
In a 71-year-old African American man who is confused (oriented to person and place only), has had multiple falls, decreased appetite, and no known drug allergies, what medication(s) should be prescribed?
What is the appropriate acute management for aldrin poisoning?
Does calcium and vitamin D supplementation improve osteopenia and normalize serum calcium and 25‑hydroxyvitamin D levels?
For a 64-year-old male with type 1 diabetes, weighing 82 kg, remote history of failed pancreas transplant and recent free flap reconstruction, who is on insulin glargine (Lantus) 14 U daily and uses an insulin‑to‑carbohydrate ratio of 1 U per 11 g, what should his inpatient Lantus dose be?
In a previously healthy 4‑month‑old uncircumcised boy presenting with fever and urinalysis showing nitrite positivity, leukocyturia (30‑40 cells/HPF), and hematuria (5‑10 RBCs/HPF), what is the most appropriate empiric antimicrobial therapy?
In patients aged 60 years and older undergoing major non‑cardiac surgery, does maintenance anesthesia with sevoflurane versus propofol reduce postoperative delirium, long‑term cognitive decline, and mortality?
In the United States, is the Signatera (personalized circulating tumor DNA) assay used to monitor breast cancer?
For a 64-year-old man with type 1 diabetes who uses an insulin-to-carbohydrate ratio of 1 unit per 12 g at home and receives 10 mg intravenous dexamethasone, what should his inpatient insulin-to-carbohydrate ratio be?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.